Wells Fargo maintains its Market Perform rating on BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) following a presentation by its CFO, Dan ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE